Trial intelligence / Profile preview

Pentoxifylline for Ventricular Arrhythmia

IRCT20220516054874N16Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Jun 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of pentoxifylline in ventricular arrhythmia (VA), sponsored by Mashhad University of Medical Sciences. Started Jun 2024; status: completed.

02

Drugs

pentoxifylline
03

Conditions

ventricular arrhythmia (VA)

Beyond the preview

Go deeper on IRCT20220516054874N16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220516054874N16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call